Literature DB >> 33863828

Pulse arrival time, a novel sleep cardiovascular marker: the multi-ethnic study of atherosclerosis.

Younghoon Kwon1, Christopher Wiles2, B Eugene Parker2, Brian R Clark2, Min-Woong Sohn3, Sara Mariani4, Jin-Oh Hahn5, David R Jacobs6, James H Stein7, Joao Lima8, Vishesh Kapur9, Andrew Wellman4, Susan Redline10, Ali Azarbarzin4.   

Abstract

BACKGROUND: Pulse arrival time (PAT) is commonly used to estimate blood pressure response. We hypothesised that PAT response to obstructive respiratory events would be associated with increased cardiovascular risk in people with obstructive sleep apnoea.
METHODS: PAT, defined as the time interval between electrocardiography R wave and pulse arrival by photoplethysmography, was measured in the Multi-Ethnic Study of Atherosclerosis Sleep study participants. The PAT response to apnoeas/hypopnoeas was defined as the area under the PAT waveform following respiratory events. Cardiovascular outcomes included markers of subclinical cardiovascular disease (CVD): left ventricular mass, carotid plaque burden score and coronary artery calcification (CAC) (cross-sectional) and incident composite CVD events (prospective). Multivariable logistic and Cox proportional hazard regressions were performed.
RESULTS: A total of 1407 participants (mean age 68.4 years, female 47.5%) were included. Higher PAT response (per 1 SD increase) was associated with higher left ventricular mass (5.7 g/m2 higher in fourth vs first quartile, p<0.007), higher carotid plaque burden score (0.37 higher in fourth vs first quartile, p=0.02) and trended to greater odds of CAC (1.44, 95% CI 0.98 to 2.15, p=0.06). A total of 65 incident CVD events were observed over the mean of 4.1 (2.6) years follow-up period. Higher PAT response was associated with increased future CVD events (HR: 1.20, 95% CI 1.02 to 1.42, p=0.03).
CONCLUSION: PAT is independently associated with markers of subclinical CVD and incident CVD events. Respiratory-related PAT response is a novel and promising polysomnography metric with cardiovascular implications. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  clinical epidemiology; sleep apnoea

Mesh:

Year:  2021        PMID: 33863828      PMCID: PMC8530459          DOI: 10.1136/thoraxjnl-2020-216399

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.102


  38 in total

1.  Carotid artery plaque burden, stiffness, and mortality risk in elderly men: a prospective, population-based cohort study.

Authors:  Stefan Störk; Annewieke W van den Beld; Clemens von Schacky; Christiane E Angermann; Steven W J Lamberts; Diederick E Grobbee; Michiel L Bots
Journal:  Circulation       Date:  2004-07-06       Impact factor: 29.690

Review 2.  Is obstructive sleep apnoea causally related to arterial stiffness? A critical review of the experimental evidence.

Authors:  Craig L Phillips; Mark Butlin; Keith K Wong; Alberto P Avolio
Journal:  Sleep Med Rev       Date:  2012-06-01       Impact factor: 11.609

3.  Continuous blood pressure measurement using the pulse transit time: Comparison to intra-arterial measurement.

Authors:  Andreas Patzak; Yuri Mendoza; Heiko Gesche; Martin Konermann
Journal:  Blood Press       Date:  2015-04-10       Impact factor: 2.835

Review 4.  Left ventricular hypertrophy as a predictor of cardiovascular risk.

Authors:  Philippe Gosse
Journal:  J Hypertens Suppl       Date:  2005-04

5.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

Authors:  R B Devereux; D R Alonso; E M Lutas; G J Gottlieb; E Campo; I Sachs; N Reichek
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

6.  Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.

Authors:  Joseph Yeboah; Robyn L McClelland; Tamar S Polonsky; Gregory L Burke; Christopher T Sibley; Daniel O'Leary; Jeffery J Carr; David C Goff; Philip Greenland; David M Herrington
Journal:  JAMA       Date:  2012-08-22       Impact factor: 56.272

7.  Toward Ubiquitous Blood Pressure Monitoring via Pulse Transit Time: Theory and Practice.

Authors:  Ramakrishna Mukkamala; Jin-Oh Hahn; Omer T Inan; Lalit K Mestha; Chang-Sei Kim; Hakan Töreyin; Survi Kyal
Journal:  IEEE Trans Biomed Eng       Date:  2015-06-05       Impact factor: 4.538

8.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

Review 9.  Blood pressure monitoring in sleep: time to wake up.

Authors:  Younghoon Kwon; Patrick L Stafford; Diane C Lim; Sungha Park; Sung-Hoon Kim; Richard B Berry; David A Calhoun
Journal:  Blood Press Monit       Date:  2020-04       Impact factor: 1.430

10.  Comparison of Carotid Plaque Score and Coronary Artery Calcium Score for Predicting Cardiovascular Disease Events: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Adam D Gepner; Rebekah Young; Joseph A Delaney; Matthew J Budoff; Joseph F Polak; Michael J Blaha; Wendy S Post; Erin D Michos; Joel Kaufman; James H Stein
Journal:  J Am Heart Assoc       Date:  2017-02-14       Impact factor: 5.501

View more
  2 in total

1.  All-Cause Mortality in People with Co-Occurring Insomnia Symptoms and Sleep Apnea: Analysis of the Wisconsin Sleep Cohort.

Authors:  Bastien Lechat; Kelly A Loffler; Douglas M Wallace; Amy Reynolds; Sarah L Appleton; Hannah Scott; Andrew Vakulin; Nicole Lovato; Robert Adams; Danny J Eckert; Peter G Catcheside; Alexander Sweetman
Journal:  Nat Sci Sleep       Date:  2022-10-13

2.  Multinight Prevalence, Variability, and Diagnostic Misclassification of Obstructive Sleep Apnea.

Authors:  Bastien Lechat; Ganesh Naik; Amy Reynolds; Atqiya Aishah; Hannah Scott; Kelly A Loffler; Andrew Vakulin; Pierre Escourrou; R Doug McEvoy; Robert J Adams; Peter G Catcheside; Danny J Eckert
Journal:  Am J Respir Crit Care Med       Date:  2022-03-01       Impact factor: 30.528

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.